Week1

From 2009.igem.org

(Difference between revisions)
 
(2 intermediate revisions not shown)
Line 1: Line 1:
-
1.LB and M9 Preparation
+
{| style="color:#000000;background-color:#ffffff;" cellpadding="6" cellspacing="3" border="0" bordercolor="#ffffff" width="65%" align="center"
-
2.Ampicillin stock-100X (X=100 microg/ml)
+
!align="center"|[[Team:IIT_Bombay_India|Home]]
 +
!align="center"|[[Team:IIT_Bombay_India/Team|The Team]]
 +
!align="center"|[[Team:IIT_Bombay_India/Project|The Project]]
 +
!align="center"|[[Team:IIT_Bombay_India/Analysis|Analysis]]
 +
!align="center"|[[Team:IIT_Bombay_India/Modeling|Modeling]]
 +
!align="center"|[[Team:IIT_Bombay_India/Notebook|Notebook]]
 +
!align="center"|[[Team:IIT_Bombay_India/Safety|Safety]]
 +
|}
-
3.Growth Curve of CFP and YFP  
+
 
 +
 
 +
[[Image:IITB-Home.jpg]]
 +
 
 +
{| background-color:#ffffff;" cellpadding="1.5" cellspacing="2" border="0" bordercolor="#ffffff" width="90%" align="center"
 +
!align="left"|
 +
 
 +
|
 +
 
 +
1.LB and M9 Medium  Preparation
 +
 
 +
2.Ampicillin stock-100X (X=100 microg/ml)
 +
 
 +
3.Growth Curve of strains having CFP and YFP on LB and M( medium.
4.Trial FACS run with 100microM of IPTG for CFP and YFP (without controls)- signal obtained
4.Trial FACS run with 100microM of IPTG for CFP and YFP (without controls)- signal obtained

Latest revision as of 01:36, 22 October 2009

Home The Team The Project Analysis Modeling Notebook Safety


IITB-Home.jpg

1.LB and M9 Medium Preparation

2.Ampicillin stock-100X (X=100 microg/ml)

3.Growth Curve of strains having CFP and YFP on LB and M( medium.

4.Trial FACS run with 100microM of IPTG for CFP and YFP (without controls)- signal obtained

Retrieved from "http://2009.igem.org/Week1"